Annovis Partners with NeuroRPM to Deploy AI-Powered Digital Biomarker Technology in Parkinson's Disease Study
· annovis bio inc.
AI Briefing
- Annovis Bio partners with NeuroRPM to deploy AI-powered digital biomarker technology in Parkinson's disease study
- Annovis is developing an investigational oral therapy for neurodegenerative diseases
- The partnership aims to collect movement data for symptom and disease management
Advertisement